The incidence of esophageal adenocarcinoma (EAC) in the western world has been rapidly increasing. The trends in obesity and other lifestyle-associated factors have been hypothesized to be important drivers of this increase. We tested this hypothesis by comparing changes in these factors with changes in EAC incidence over time between three western countries.
INTRODUCTION
Esophageal cancer is the eight most common cancer in the world and because of its high fatality rate, ranks sixth among all cancers with respect to mortality ( 1 ) . Th e cases can be divided into two major histological types, squamous cell carcinoma and esophageal adenocarcinoma (EAC). In countries where incidence rates of EAC have been examined, there has been a sharp increase in cancer incidence over the last few decades ( 2 -10 ), whereas rates of squamous cell carcinoma have remained relatively stable. In many western countries (3,5,6,10 -13) , incidence of EAC has increased more rapidly than any other malignancy, with an average annual increases up to 8.2 % for males during the past two or three decades.
EAC is assumed to develop from Barrett ' s esophagus (BE) ( 14 -16 ) . BE is presumed to be a complication of gastroesophageal-refl ux disease and symptoms of gastro-esophagealrefl ux disease such as heartburn and / or acid regurgitation are associated with EAC ( 17, 18 ) . Two lifestyle-associated factors believed to be associated with the development of EAC are obesity and smoking ( 19, 20 
METHODS

Incidence
We used the Surveillance, Epidemiology, and End Results database (SEER)-9 to abstract the US EAC incidence data from 1975 to 2009 for white males and females (C15, ICD-O: 8,140 -8,149, 8,160 -8,231, 8,250 -8,499, 8,501 -8,574, 8,576) . SEER-9 has information on all diagnosed malignancies among residents of the nine original SEER geographic areas, representing approximately 10 % of the population of the United States. From 1975 to 2009, a total of 13,225 EAC cases were registered for white race, both sexes. Spanish data were obtained from 13 population-based cancer registries in Spain from 1980 to 2004 for the incidence of adenocarcinoma in the esophagus (C15, ICD-O: 8,140 -8,570) ( 3 ) . Th e 13 registries cover approximately 26 % of the total Spanish population and have collected data for at least 10 consecutive years of the study period. From 1980 to 2004, a total of 1,503 cases of EAC were registered for both sexes. Incidence data for the Netherlands were obtained from the Eindhoven Cancer Registry, which collects data on all newly diagnosed malignancies in the South of the Netherlands, covering 13 % of the Dutch population. From 1974 to 2010, 1,680 EAC cases were registered for both sexes (C15, ICD-O codes similar to the United States).
Obesity
Obesity was defi ned as a body mass index of 30 kg / m 2 or more. Available data on obesity may be measured (the weight and height of a person are directly measured by trained observers) or selfreported (gathered through questionnaire surveys). Although self-reported obesity data can be biased, leading to lower obesity prevalence than measured obesity data (23 -28), we chose to use self-reported data because these were abstracted from larger national surveys instead of measured obesity data gathered by smaller local studies in Spain and the Netherlands. Self-reported obesity data obtained by national surveys are available for the United States (NHIS, 1997 -2009 all races) ( 29 ) , Spain (NHS, 1987 (NHS, -2009 ( 15, 30 ) , and the Netherlands (CBS, 1981 (CBS, -2009 ( 31 ) . We abstracted these data from the Organization for Economic Co-operation and Development database ( 32 ) . To obtain estimates for self-reported obesity data in the United States before 1997, we developed a linear regression model using data abstracted from the NHANES ( 33 ) national survey, which has obtained measured obesity data in the United States since 1961. A linear regression model was fi tted to data from the overlapping time horizon (1997 -2009) and the model was used to estimate self-reported obesity before 1997 (self-reported obesity prevalence = 0.75 × me asured obesity prevalence).
Smoking
Smoking prevalence was defi ned as the prevalence of adult smokers (daily and occasional) in the population. Th e United States data were abstracted from NHANES (1965 -2010, all races) ( 34 ) . Before 1992, only daily smokers were registered, but since 1992 these data also include occasional smokers. Spanish smoking prevalence was derived from the various national and European health surveys (1978 -2009) ( 15, 30, 32, 34 ) where current smoking was defi ned as daily and occasional, over age 16. As there were no data available before 1978, we used the estimated prevalence for daily smokers from 1945 to 1975 ( 35 ) . For the Netherlands, the smoking prevalence was abstracted from STIVORO (1958 STIVORO ( -2010 , reporting daily and occasional smokers over age 15 ( 36 ) .
Alcohol
We defi ned alcohol use as the recorded adult (15 + ) annual a lcohol consumption per capita by country. Th e data for the three countries were obtained from the World Health Organization (WHO) data repository ( 37 ) (1962 -2009 ).
Statistical analysis
Annual EAC incidence rates were calculated per 100,000 person-years, and were age standardized to the European standard population ( 38 ) . Temporal trends were assessed using joinpoint regression, for which the Joinpoint regression program (version 3.5.2; Statistical Research and Applications Branch, National Cancer Institute, Bethesda, MD ) from the Surveillance Research Program of the US National Cancer Institute was used.
Joinpoint regression analysis fi nds the best-fi t line through trend data, and tests whether a set of multi-segmented lines is a significantly better fi t than a single line. Th e intersections of lines are called joinpoints with each joinpoint denoting a statistically signifi cant ( P = 0.05) change in trend. Each line segment between two joinpoints can be characterized with the estimated annual percentage of change (EAPC), refl ecting a change in trend data at a constant percentage of the rate of the previous year within the time horizon of the line segment. Th e joinpoint regression analysis fi ts a series of joined straight lines on a log scale to the trends using y = ax + b , where y = ln(rate of trend data), x = calendar year and a = slope coeffi cient. Th e EAPC is calculated from the equation: (EAPC = 100 × ( e a − 1)) ( 39, 40 ) . Th e average annual percentage of change (AAPC) was used to analyze diff erences in the slopes of the time trends of time horizons we compared, which was the longest available time horizon for which trend data were available in all three countries. Th e diff erence between two AAPCs was obtained by using the approximate 95 % confi dence interval (CI) with the estimated diff erence of AAPC
(1) -AAPC (2) .
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RESULTS
Incidence
In 1980, the fi rst year of commonly available data, EAC incidence was comparable in the three countries (United States 0.63 / 100,000, the Netherlands 0.55 / 100,000, and Spain 0.46 / 100,000; Figure 1 ). In subsequent years, however, both the United States and the Netherlands reported a greater increase in incidence than Spain. Th e incidence in the Netherlands was comparable to the United States incidence until 1998; thereaft er, EAC incidence in the Netherlands exceeded the United States incidence. For the complete period 1975 -2009, the rate at which EAC incidence increased was signifi cantly greater in Netherlands (AAPC = 9.6, 95 % CI 8. 
Obesity
Th e obesity trends for the three countries demonstrate a diff erent sequence than the EAC incidence trends ( Figure 2a ). From 1987 onward, the United States has had the highest obesity prevalence (15.0 % ), followed by Spain (6.8 % ), and the Netherlands (5.3 % ); this order is preserved throughout the entire observation period. In the last year of observation (2009), the obesity prevalence had increased to 27.7 % , 16.0 % , and 11.8 % , respectively, for the United States, Spain, and the Netherlands.
Smoking
In 1965, the fi rst year of commonly available data, smoking prevalence was highest in the Netherlands (58.7 % ), followed by the United States (41.9 % ), and Spain (21.6 % ). Th is sequencing was altered when the Spanish smoking prevalence increased from 1965 to a peak in 1985, exceeding that of the Netherlands and the United States ( Figure 2b ). Both the United States and the Netherlands had decreasing smoking prevalence ( Table 2 ) through the whole observation period. In the fi nal year of commonly available data (2009), the smoking prevalence was highest in Spain (29.9 % ), followed by the Netherlands (28.0 % ), and the United States (20.6 % ).
Alcohol
In 1962, the highest annual alcohol consumption per capita was in Spain (14.6 l), followed by the United States (8.0 l), and the Netherlands (4.3 l) ( Table 1 ) . Spain continued to have the highest alcohol consumption per capita during the observation time frame, although aft er a peak in 1976 consumption decreased to a consumption level comparable to the Netherlands in 2005 ( Figure 2c ). Th e Netherlands has exceeded the United States trend since 1973. In 2009, the alcohol consumption was highest in Spain (11.4 l), followed by the Netherlands (9.2 l), and the United States (8.7 l).
Trends by sex
Th ere is a large diff erence in the EAC incidence rates between males and females. Female EAC incidence in the Netherlands is greater than the United States through the entire observation period, while the male EAC incidence in the Netherlands exceeds the United States aft er 2003. In both males and females, the lowest rates are seen in Spain. Identical country sequencing is found in the obesity trends for males and females. Th e diff erences between male and female obesity prevalence are similar among the Netherlands and the United States, with the uniform feature of higher female obesity prevalence. In Spain, male obesity has exceeded female obesity since 2006.
For smoking prevalence, the United States and the Netherlands show similar trends for males and females, both having decreased since 1967, with males having a higher smoking prevalence than females. In Spain, male smoking prevalence peaked in the 1970s, when the female prevalence was still negligible, whereas female prevalence peaked aft er the 1990s.
For the alcohol consumption per capita, no sex-specifi c data are available, although we assume that alcohol consumption is higher in men than in women ( 41 ) . In the Supplementary Files online, sex-specifi c tables and fi gures for EAC incidence, obesity, and smoking prevalence are shown.
DISCUSSION
EAC incidence in the United States, Spain, and the Netherlands show large diff erences in both absolute rates and time trends; however, all trends have increased over time. Time trends for obesity, smoking, and alcohol in these countries, however, do not correlate with EAC incidence trends. Th ese fi ndings suggest that even if obesity were to provide a mechanism supporting the development of EAC, alternative factors must be the underlying drivers for the increasing incidence of EAC.
We analyzed time trends for diff erent lifestyle-associated factors. Although obesity is increasing in all three countries, the increase in Spain is greater than in the United States Moreover, the Netherlands has a greater increase in EAC incidence than the United States, but there was no diff erence in the AAPCs of obesity between the Netherlands and the United States (1981 -2009). Regarding smoking, a prior pooled analysis revealed an odds ratio of 1.96 for ever smokers vs. never smokers ( 20 ) . However, the expected lag between exposure and cancer would be no > 50 years; therefore, the absence of an observed decrease in EAC incidence suggests smoking is not an important risk factor. Finally, the trends do not support alcohol to be a risk factor for EAC ( Table 3 ) . When interpreting the time trends several alternative explanations for the increasing EAC incidence may be postulated. First, the time trends might refl ect changes in diagnostics. With the refi nement of various diagnostic modalities and the increased use of endoscopy among patients with gastro-esophageal-refl ux disease symptoms or BE, increased diagnosis might be a reason for the observed increased incidence of EAC. As there has been a concomitant increase in EAC mortality, it is unlikely that changes in diagnostics are a major infl uence on EAC incidence. Second, a reclassifi cation of tumors could result in an observed increase in EAC incidence. However, changes in reclassifi cation of tumors would be expected to show corresponding reductions in tumors adjacent to the esophagus, which have not been observed. Gastric cardia incidence has remained stable in all of the examined countries for the last two decades. In addition, we observed a steady rise of EAC incidence, instead of a discrete change that would represent reclassifi cation infl uences. Finally, although the trends imply that obesity, smoking, and alcohol are not the primary cause for the rise in EAC incidence, it is possible that the eff ect of these risk factors could be masked by an unknown protective factor with diff erential prevalence across the countries. Specifi cally, the potential protective eff ects of medication such as aspirin, proton pump inhibitors, or statins could counter the aggravating factors of obesity, tobacco, or alcohol.
If the incidence of EAC is increasing, yet not caused by obesity or smoking alternative explanations must be sought. Chronic Helicobacter pylori ( H. pylori ) infection has been hypothesized to protect against gastro-esophageal-refl ux disease and BE due to induction of atrophic gastritis and hypochlorhydria ( 42 ) . Advances in sanitation and the widespread use of antibiotics have been postulated to contribute to the decline in H. pylori infection, especially in western countries. Th erefore, it is conceivable that the increase in EAC incidence in western countries may be in part caused by the decline in H. pylori colonization rates ( 43, 44 ) . As a result of the paucity on H. pylori infection trend data across the countries, we were not able to include this factor in our study.
We chose to include the United States, Spain, and the Netherlands in our study because while the incidence rates of EAC are increasing in all countries, the rate of change diff ers, and the trends in lifestyle-associated factors vary greatly. Although several prior studies have compared EAC incidence between multiple countries (2,5,10,45,46) , only one examined trends in diff erences in absolute prevalence and prevalence changes over time between countries do not match the EAC incidence trend, as would be expected if obesity were the most signifi cant risk factor. Moreover, a comparison between Spain and the United States reveals a reverse relationship; whereas the increase in EAC incidence is greater in the United States than Spain, the obesity 
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risk factors ( 10 ). Our study is unique because we have simultaneously compared EAC incidence rates between three countries and the trends in lifestyle-associated factors hypothesized to cause EAC, which is also the strength of this study. If we would have analyzed the trends for each country individually, our conclusions might have been diff erent. Looking only at the United States, we may have supported the hypothesis that obesity and smoking are drivers for the EAC trend as obesity has the steepest slope in the lifestyle factor trend data. For the Netherlands, we would have concluded that smoking might be the driving lifestyle factor because the obesity increase starts increasing relatively late in time. For Spain, the conclusion would be that smoking and alcohol consumption would have no infl uence on EAC increase at all, and obesity is the only supporting lifestyle factor. However, by examining all countries simultaneously, it appears that smoking and obesity cannot be the main drivers because their trends are inconsistent among the three countries.
Although the inclusion of multiple countries is a strength of this study, analyzing time trends between countries also has limitations. First, defi nitions of predictors and outcomes can be dissimilar between various data sources. For example, morphology codes for EAC incidence diff ered slightly between Spain and the other countries. Using the Spanish morphology codes in the United Smoking is a driver of the increase in EAC Supports: the country sequencing of EAC incidence and smoking prevalence may correlate, but only with a lag time > 50 years.
Does not support: prevalence of smoking is decreasing in all countries.
Alcohol is a driver of the increase in EAC Does not support: the country sequencing of alcohol consumption does not correlate with EAC incidence.
Does not support: alcohol consumption is decreasing, while EAC incidence is increasing in all countries.
CI, confi dence interval; EAC, esophageal adenocarcinoma. a Signifi cant, 95 % CI. 
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States would result in an increase of 0.33 % in total EAC cases from 1975 to 2009. In addition, EAC incidence trends in the United States were based on whites only for comparability with rates in Spain and the Netherlands. However, long-term data for obesity were available for the total population only. Given the comparability of trends between blacks and whites and the fact that whites constitute a large majority of the population, we do not expect this to substantially infl uence our results. Second, there were variations in ages, collection methods, and inclusion criteria between the three countries. However, we do not believe this variation infl uenced our results signifi cantly because we examined trend data that were highly correlated over ages, collection methods, and inclusion criteria. Th ird, the available time horizons of the data were dissimilar between countries for lifestyle-associated factors and EAC incidence trends. However, the overlapping periods were suffi cient for testing our hypothesis whether these factors could be main drivers for the increasing EAC incidence. Furthermore, the level of detail available for the risk factors we studied was limited.
We were unable to identify the quantity of smoking by country and sex, and the composition of cigarettes for each country. Th e distribution of alcohol consumption in the population, and the type of alcohol consumption would refl ect more specifi c trends. Th e consumption of wine has been signifi cantly larger in Spain than the two other countries, while the consumption of beer was modestly largest in the Netherlands up to 2006. Th ese diff erences, as well as diff erences in quantity of smoking may infl uence the risk for EAC incidence. Fourth, results of ecological analysis at the population level may not refl ect associations at the individual level. Furthermore, interactions between the lifestyle factors and development of EAC cannot be analyzed in this study design. Fift h, diff erences in health-care practices and adoption of new practices between the three countries could not be specifi ed and implemented in our analysis. Finally, it is possible that the time period was insuffi cient to observe the impact of lifestyle factors on EAC incidence. If smoking and obesity are associated with the development of BE, the impact of these factors on EAC may require a long lag time.
In conclusion, international trends in lifestyle-associated factors most commonly implicated in EAC development, including obesity, are discordant with the trends in EAC incidence. Th is analysis suggests that other important drivers for the increase in EAC incidence in the three observed countries must be present.
